# Alpa Laboratories Ltd (ALPA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹68
Day Change: -1.68%
52W High: ₹118.8
52W Low: ₹46
Market Cap: ₹148 Cr

## Valuation
P/E: 12.71
P/B: 0.86
EPS: ₹5.52
Book Value: ₹81.47
Dividend Yield: 0%

## Returns
1Y Return: -19.21%

## Profitability
ROE: 0%
ROCE: 3.02%
Debt/Equity: 0
Revenue Growth: 11.1%
Profit Growth: -78.7%
EBITDA Margin: -0.19%
Operating Margin: 2.97%

## About
Alpa Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Alpa Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Announcement: Appointment of Company Secretary and Compliance Officer
- BSE Filing: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-25T12:00:11.977Z
Price History Updated: 2026-05-25T05:24:18.496Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:24:18.496Z
Quant Updated: 2026-05-25T05:24:18.496Z
Sentiment Updated: 2026-05-25T05:24:18.496Z
Financials Status: current
Financials Updated: 2026-05-18T23:04:50.182Z
Financials Last Attempt: 2026-05-18T23:04:50.182Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹56 Cr
Operating Profit: ₹6 Cr (OPM 10%)
Net Profit: ₹-5 Cr
Tax: ₹-5 Cr

## Annual P&L History
Mar 2015: Rev ₹56Cr | PAT ₹-5Cr | OPM 10%
Mar 2016: Rev ₹57Cr | PAT ₹-1Cr | OPM 6%
Mar 2017: Rev ₹53Cr | PAT ₹7Cr | OPM 13%

## Balance Sheet (Mar 2015)
Total Assets: ₹127 Cr
Total Liabilities: ₹127 Cr
Borrowings: ₹23 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Mahendra Singh Chawla, Chairman of the Board
- Paresh  Chawla, MD & Director
- Bakulesh Chandulal Shah, Chief Financial Officer
- Pravin C. Shah, Executive Whole-Time Director
- Shitul  Shah, Whole Time Director

---
Source: rupiya.io/stocks/alpa
Disclaimer: For research and education only. Not investment advice.